Li G - Search Results

1

p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization.

Peng J, Li J, Huang J, Xu P, Huang H, Liu Y, Yu L, Yang Y, Zhou B, Jiang H, Chen K, Dang Y, Zhang Y, Luo C, Li G. Peng J, et al. Among authors: li j, li g. Theranostics. 2019 Oct 22;9(26):8344-8361. doi: 10.7150/thno.30707. eCollection 2019. Theranostics. 2019. PMID: 31754401 Free PMC article.

2

Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation.

Huang HM, Zhou XR, Liu YJ, Fan SJ, Liao LP, Huang J, Shi CC, Yu L, Pen JJ, Luo C, Zhang YY, Li GM. Huang HM, et al. Mol Med Rep. 2021 May;23(5):305. doi: 10.3892/mmr.2021.11944. Epub 2021 Mar 2. Mol Med Rep. 2021. PMID: 33649839 Free PMC article.

3

Cyclin-dependent kinase inhibitor roscovitine attenuates liver inflammation and fibrosis by influencing initiating steps of liver injury.

Liu Y, Li J, Liao L, Huang H, Fan S, Fu R, Huang J, Shi C, Yu L, Chen KX, Zhang YY, Luo C, Li GM. Liu Y, et al. Clin Sci (Lond). 2021 Apr 16;135(7):925-941. doi: 10.1042/CS20201111. Clin Sci (Lond). 2021. PMID: 33786590

4

Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis.

Huang HM, Fan SJ, Zhou XR, Liu YJ, Li X, Liao LP, Huang J, Shi CC, Yu L, Fu R, Fan JG, Zhang YY, Luo C, Li GM. Huang HM, et al. Acta Pharmacol Sin. 2022 Apr;43(4):941-953. doi: 10.1038/s41401-021-00725-1. Epub 2021 Aug 2. Acta Pharmacol Sin. 2022. PMID: 34341511 Free PMC article.

5

Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis.

Fu R, Zu SJ, Liu YJ, Li JC, Dang WZ, Liao LP, Liu LP, Chen PY, Huang HM, Wu KH, Zhou B, Pan Q, Luo C, Zhang YY, Li GM. Fu R, et al. Bioengineered. 2022 Apr;13(4):10914-10930. doi: 10.1080/21655979.2022.2066756. Bioengineered. 2022. PMID: 35499161 Free PMC article.

6

Hepatitis B-related glomerulonephritis and optimization of treatment.

Liu Y, Shi C, Fan J, Wang B, Li G. Liu Y, et al. Among authors: li g. Expert Rev Gastroenterol Hepatol. 2020 Feb;14(2):113-125. doi: 10.1080/17474124.2020.1717948. Epub 2020 Jan 23. Expert Rev Gastroenterol Hepatol. 2020. PMID: 31951758 Review.

7

Protective Effects of Oridonin on Acute Liver Injury via Impeding Posttranslational Modifications of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) in the Toll-Like Receptor 4 (TLR4) Signaling Pathway.

Shi M, Deng Y, Yu H, Xu L, Shi C, Chen J, Li G, Du Y, Wang YG. Shi M, et al. Among authors: li g. Mediators Inflamm. 2019 Sep 12;2019:7634761. doi: 10.1155/2019/7634761. eCollection 2019. Mediators Inflamm. 2019. PMID: 31611735 Free PMC article.

8

Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis.

Guo XY, He CX, Wang YQ, Sun C, Li GM, Su Q, Pan Q, Fan JG. Guo XY, et al. Biomed Res Int. 2017;2017:5936171. doi: 10.1155/2017/5936171. Epub 2017 Jun 21. Biomed Res Int. 2017. PMID: 28717649 Free PMC article.

9

[Statins in chronic liver diseases: safety and effect].

Li GM, Fan JG. Li GM, et al. Zhonghua Gan Zang Bing Za Zhi. 2010 Jun;18(6):478-80. doi: 10.3760/cma.j.issn.1007-3418.2010.06.022. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 20587326 Review. Chinese. No abstract available.

10

Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats.

Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, Zhou H, Lu H, Jin Y. Li G, et al. Among authors: li d. J Gene Med. 2006 Jul;8(7):889-900. doi: 10.1002/jgm.894. J Gene Med. 2006. PMID: 16652398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46,065 results

Search Page